Literature DB >> 10082370

Role of the 6-20 disulfide bridge in the structure and activity of epidermal growth factor.

K J Barnham1, A M Torres, D Alewood, P F Alewood, T Domagala, E C Nice, R S Norton.   

Abstract

Two synthetic analogues of murine epidermal growth factor, [Abu6, 20] mEGF4-48 (where Abu denotes amino-butyric acid) and [G1, M3, K21, H40] mEGF1-48, have been investigated by NMR spectroscopy. [Abu6, 20] mEGF4-48 was designed to determine the contribution of the 6-20 disulfide bridge to the structure and function of mEGF. The overall structure of this analogue was similar to that of native mEGF, indicating that the loss of the 6-20 disulfide bridge did not affect the global fold of the molecule. Significant structural differences were observed near the N-terminus, however, with the direction of the polypeptide chain between residues four and nine being altered such that these residues were now located on the opposite face of the main beta-sheet from their position in native mEGF. Thermal denaturation experiments also showed that the structure of [Abu6, 20] mEGF4-48 was less stable than that of mEGF. Removal of this disulfide bridge resulted in a significant loss of both mitogenic activity in Balb/c 3T3 cells and receptor binding on A431 cells compared with native mEGF and mEGF4-48, implying that the structural changes in [Abu6, 20] mEGF4-48, although limited to the N-terminus, were sufficient to interfere with receptor binding. The loss of binding affinity probably arose mainly from steric interactions of the dislocated N-terminal region with part of the receptor binding surface of EGF. [G1, M3, K21, H40] mEGF1-48 was also synthesized in order to compare the synthetic polypeptide with the corresponding product of recombinant expression. Its mitogenic activity in Balb/c 3T3 cells was similar to that of native mEGF and analysis of its 1H chemical shifts suggested that its structure was also very similar to native.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10082370      PMCID: PMC2144085          DOI: 10.1002/pro.5560070808

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  50 in total

1.  Native and non-native structure in a protein-folding intermediate: spectroscopic studies of partially reduced IGF-I and an engineered alanine model.

Authors:  Q X Hua; L Narhi; W Jia; T Arakawa; R Rosenfeld; N Hawkins; J A Miller; M A Weiss
Journal:  J Mol Biol       Date:  1996-06-07       Impact factor: 5.469

2.  Simulated annealing with restrained molecular dynamics using CONGEN: energy refinement of the NMR solution structures of epidermal and type-alpha transforming growth factors.

Authors:  R Tejero; D Bassolino-Klimas; R E Bruccoleri; G T Montelione
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

3.  Three-dimensional structure in solution of neurotoxin III from the sea anemone Anemonia sulcata.

Authors:  N Manoleras; R S Norton
Journal:  Biochemistry       Date:  1994-09-20       Impact factor: 3.162

4.  Synthesis and characterization of leiurotoxin I analogs lacking one disulfide bridge: evidence that disulfide pairing 3-21 is not required for full toxin activity.

Authors:  J M Sabatier; C Lecomte; K Mabrouk; H Darbon; R Oughideni; S Canarelli; H Rochat; M F Martin-Eauclaire; J van Rietschoten
Journal:  Biochemistry       Date:  1996-08-20       Impact factor: 3.162

5.  Contribution of individual disulfide bonds to biological action of Escherichia coli heat-stable enterotoxin B.

Authors:  Y L Arriaga; B A Harville; L A Dreyfus
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Structural analysis of a biologically active echistatin analogue des(46-49)-[Ala8,37]-echistatin gamma with three disulfide bonds by 2D-NMR and computer graphics.

Authors:  L C Chuang; P Y Chen; C Chen; T H Huang; K T Wang; S H Chiou; S H Wu
Journal:  Biochem Biophys Res Commun       Date:  1996-03-18       Impact factor: 3.575

7.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

8.  Extensive nonrandom structure in reduced and unfolded bovine pancreatic trypsin inhibitor.

Authors:  H Pan; E Barbar; G Barany; C Woodward
Journal:  Biochemistry       Date:  1995-10-31       Impact factor: 3.162

9.  Solution structure of the cardiostimulant polypeptide anthopleurin-B and comparison with anthopleurin-A.

Authors:  S A Monks; P K Pallaghy; M J Scanlon; R S Norton
Journal:  Structure       Date:  1995-08-15       Impact factor: 5.006

10.  1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects.

Authors:  D S Wishart; C G Bigam; A Holm; R S Hodges; B D Sykes
Journal:  J Biomol NMR       Date:  1995-01       Impact factor: 2.835

View more
  12 in total

Review 1.  Early engineering approaches to improve peptide developability and manufacturability.

Authors:  Jennifer L Furman; Mark Chiu; Michael J Hunter
Journal:  AAPS J       Date:  2014-10-23       Impact factor: 4.009

2.  Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains.

Authors:  René Bager; Thomas K Kristensen; Jan K Jensen; Agnieszka Szczur; Anni Christensen; Lisbeth M Andersen; Jesper S Johansen; Niels Larsen; Erik Baatrup; Mingdong Huang; Michael Ploug; Peter A Andreasen
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

3.  Temperature-induced unfolding of epidermal growth factor (EGF): insight from molecular dynamics simulation.

Authors:  Chunli Yan; Varun Pattani; James W Tunnell; Pengyu Ren
Journal:  J Mol Graph Model       Date:  2010-04-04       Impact factor: 2.518

Review 4.  Growth factors: possible roles for clinical management of the short bowel syndrome.

Authors:  Mark E McMellen; Derek Wakeman; Shannon W Longshore; Lucas A McDuffie; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

5.  Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.

Authors:  Keith K Khoo; Zhi-Ping Feng; Brian J Smith; Min-Min Zhang; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj; Raymond S Norton
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

Review 6.  Targeted therapies in gastric cancer and future perspectives.

Authors:  Ozan Yazici; M Ali Nahit Sendur; Nuriye Ozdemir; Sercan Aksoy
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

7.  Cyclic analogues of α-conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain.

Authors:  Joel Castro; Luke Grundy; Annemie Deiteren; Andrea M Harrington; Tracey O'Donnell; Jessica Maddern; Jessi Moore; Sonia Garcia-Caraballo; Grigori Y Rychkov; Rilei Yu; Quentin Kaas; David J Craik; David J Adams; Stuart M Brierley
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

8.  The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach.

Authors:  J T Hoskins; Z Zhou; P A Harding
Journal:  Biochem Biophys Res Commun       Date:  2008-08-24       Impact factor: 3.575

9.  Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1.

Authors:  Rilei Yu; Victoria A L Seymour; Géza Berecki; Xinying Jia; Muharrem Akcan; David J Adams; Quentin Kaas; David J Craik
Journal:  Sci Rep       Date:  2015-08-20       Impact factor: 4.379

10.  Molecular targeted agents for gastric cancer: a step forward towards personalized therapy.

Authors:  Esther Una Cidon; Sara G Ellis; Yasir Inam; Sola Adeleke; Sara Zarif; Tom Geldart
Journal:  Cancers (Basel)       Date:  2013-01-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.